Nuzenio

Aatd

Aatd news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 14:10:14 GMTClosing the AATD Diagnostic Gap, With Sarah Tomashefski, MSN - HCPLive
Tue, 04 Aug 2026 14:29:21 GMTCRISPR Therapeutics Launches Clinical Trials of In Vivo Gene Editors for Hypertension, AATD - Precision Medicine Online
Tue, 04 Aug 2026 11:12:19 GMTBeam expects $1.2B cash plus $200M draw to fund plans into mid-2029 - Stock Titan
Tue, 04 Aug 2026 11:00:00 GMTBeam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - Yahoo Finance
Tue, 28 Jul 2026 07:00:00 GMTFrom ‘lost cause’ to gold rush: Biotechs swarm to cure AATD - STAT

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aatd.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.